GSK and momelotinib: JPMorgan warns of possible disappointments
U.S. bank JPMorgan has maintained its “Underweight” rating for British pharmaceutical company GSK (LON:GSK). At the same time, the analysts…
U.S. bank JPMorgan has maintained its “Underweight” rating for British pharmaceutical company GSK (LON:GSK). At the same time, the analysts…
(Reuters) – Siemens will spend 2 billion euros ($2.2 billion) on a new global investment plan, the German engineering group…
Global growth investor General Atlantic has announced that it will acquire around 20% of the shares in Atoss Software AG…
(Reuters) – European shares opened lower on Thursday, as the European Central Bank (ECB) was expected to raise borrowing costs…
(Reuters) – It has taken months of tortuous negotiations for Vodafone (NASDAQ:VOD) and CK Hutchison to agree a deal to…
(Reuters) – Bill Gates, Microsoft Corp (NASDAQ:MSFT)’s co-founder, is set to meet Chinese President Xi Jinping on Friday during his…
(Reuters) – The Federal Reserve is expected to leave interest rates unchanged on Wednesday for the first time since the…
(Reuters) – The Federal Aviation Administration (FAA) said on Wednesday it is requiring that new passenger airplanes have a secondary…
(Reuters) – Shell said it will ramp up its dividend and share buybacks while keeping oil output steady into 2030,…
Tesla (NASDAQ:TSLA) CEO Elon Musk revealed Tuesday that the electric vehicle giant production of its Class 8 EV semi-truck would…